NCT07469280

Brief Summary

The purpose of this study is to evaluate the feasibility and effects of a 12-week high-intensity progressive Inspiratory Muscle Training (IMT) program in individuals with Class III obesity (BMI ≥ 40 kg/m²) and obstructive sleep apnea (OSA). Using a single-case experimental design (SCED) with multiple baselines, the study will investigate whether this respiratory intervention can reduce the severity of sleep apnea, as measured by the Apnea-Hypopnea Index (AHI), and improve inspiratory muscle strength and sleep quality. Participants will perform daily training sessions using a resistive loading device (POWERbreathe), with intensity progressing from 40% to 90% of their maximum inspiratory pressure.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
17mo left

Started May 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
May 2026Dec 2027

First Submitted

Initial submission to the registry

March 9, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

March 9, 2026

Last Update Submit

March 18, 2026

Conditions

Keywords

Class III obesityInspiratory muscle trainingObstructive sleep apneaSingle-case experimental design

Outcome Measures

Primary Outcomes (1)

  • Apnea-Hypopnea Index (AHI)

    Number of apnea and hypopnea events per hour of sleep, measured via portable polygraphy (Type III)

    Baseline (Phase A - three measurements) and Post-Intervention (Phase B - 12th week).

Secondary Outcomes (6)

  • Maximum Inspiratory Pressure (MIP)

    Weekly assessments throughout Phase A (3 to 5 weeks) and Phase B (12 weeks).

  • Epworth Sleepiness Scale (ESS) score

    Baseline and Post-Intervention (12th week).

  • Pittsburgh Sleep Quality Index (PSQI) global score

    Baseline and Post-Intervention (12th week).

  • International Physical Activity Questionnaire (IPAQ) - Short Form

    Baseline and Post-Intervention (12th week).

  • Borg Rating of Perceived Exertion (RPE)

    Daily during the 12 weeks of intervention (Phase B).

  • +1 more secondary outcomes

Study Arms (1)

Experimental Group: High-Intensity IMT

EXPERIMENTAL

Participants will undergo a progressive high-intensity Inspiratory Muscle Training (IMT) program using a resistive loading device (POWERbreathe).

Device: High-Intensity Progressive Inspiratory Muscle Training (IMT)

Interventions

"The intervention consists of 12 weeks of inspiratory muscle training performed 5 days per week. Each session includes 30 breaths through a resistive loading device (POWERbreathe). The training intensity starts at 40% of the Maximum Inspiratory Pressure (MIP) and progressively increases to 90% of MIP. Training load is adjusted weekly based on new MIP measurements to ensure high-intensity stimulus. Compliance and adverse events will be monitored through a training diary."

Experimental Group: High-Intensity IMT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Of both genders.
  • Class III obesity (BMI \> 40 kg/m²).
  • Diagnosis of OSA.
  • Without neurological conditions that would prevent them from responding to the study assessments.

You may not qualify if:

  • Systemic diseases (pulmonary, cardiac or renal).
  • Are using medications that may affect muscle performance.
  • Are currently using CPAP therapy.
  • Conditions that could compromise adherence to the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Santa Catarina State University - CEFID (Center of Health and Sport Sciences)

Florianópolis, Santa Catarina, 88080-350, Brazil

Location

Related Publications (2)

  • GRANVILE, A. A. B. B.; BORGES, A. C. L.; RUAS, G. EFEITOS DO TREINAMENTO DE ALTA E BAIXA INTENSIDADE NA MUSCULATURA INSPIRATÓRIA EM INDIVÍDUOS OBESOS MÓRBIDOS: ESTUDO RANDOMIZADO CONTROLADO. Revista Brasileira de Obesidade, Nutrição e Emagrecimento, p. 469-478, dez. 2017.

    BACKGROUND
  • Dar JA, Mujaddadi A, Moiz JA. Effects of inspiratory muscle training in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. Sleep Sci. 2022 Oct-Dec;15(4):480-489. doi: 10.5935/1984-0063.20220081.

    PMID: 36419804BACKGROUND

MeSH Terms

Conditions

ObesitySleep Apnea, ObstructiveObesity, Morbid

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Darlan Laurício Matte, PhD

    Santa Catarina State University (UDESC)

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This study utilizes a prospective, non-concurrent multiple-baseline single-case experimental design (SCED) with stability-based phase transition. The protocol is divided into Phase A (Baseline) and Phase B (Intervention), where the start of the high-intensity inspiratory muscle training is determined by the stability of the primary outcomes during the baseline period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 9, 2026

First Posted

March 13, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

March 23, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations